BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 405977)

  • 1. Pharmacological properties of 2,3-dihydro-9H-isoxazolo[3,2-b]-quinazolin-9-one (W-2429. Part 2: General pharmacological investigation.
    Sofia RD; Diamantis W; Gordon R; Edelson J; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):782-9. PubMed ID: 405977
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological properties of 2,3-dihydro-9H-isoxazolo [3,2-b] quinazolin-9-one (W-2429. Part 1: Analgesic, antipyretic and antiedema activity.
    Sofia RD; Diamantis W; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):770-82. PubMed ID: 17418
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxicological investigation of 2,3-dihydro-9H-isoxazolo[3,2-b]quinazolin-9-one (W-2429). Acute and subacute toxicity in mice, rats and dogs.
    Banerjee BN; Sofia RD; Ivins NJ; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):793-801. PubMed ID: 301393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,3-Dihydro-9H-isoxazolo[3,2-b]quinazolin-9-ones and 3,4-dihydro-(1,2)-oxazino [3,2-b]quinazolin-10(2H)-ones.
    Reisner DB; Ludwig BJ; Simon E; Dejneka T; Sofia RD
    Arzneimittelforschung; 1977; 27(4):766-70. PubMed ID: 301391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General pharmacological properties of 4,5-diphenyl-2-bis-(2-hydroxyethyl)-aminoxazol (ditazol).
    Caprino L; Borrelli F; Falchetti R
    Arzneimittelforschung; 1973 Sep; 23(9):1283-7. PubMed ID: 4801221
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological studies of a new antitussive, 1-phenethyl-4-hydroxy-salicylamido-4-methyl-piperidine-hydrochloride (S 1592) (author's transl)].
    Duhault J; Tisserand F; Regnier G
    Arzneimittelforschung; 1976 Apr; 26(4):516-23. PubMed ID: 989005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [General pharmacological studies on tramadol, a potent analgetic agent (author's transl)].
    Osterloh G; Friderichs E; Felgenhauer F; Günzler WA; Henmi Z; Kitano T; Nakamura M; Hayashi H; Ishii I
    Arzneimittelforschung; 1978; 28(1a):135-51. PubMed ID: 305247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacology of oxepinac.
    Kojima H; Hashizume T; Chiba T; Tanaka M; Kasai Y; Kasahara A
    Arzneimittelforschung; 1978; 28(3):439-45. PubMed ID: 580753
    [No Abstract]   [Full Text] [Related]  

  • 9. Absorption, distribution and metabolic fate of 2,3-dihydro-9H-isoxazolo-[3,2-b]quinazolin-9-one (W2429).
    Edelson J; Douglas JF; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):789-93. PubMed ID: 301392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological study of some 3-(isoxazol-5-yl)-quinazolin-4(3H)-ones.
    Plescia S; Daidone G; Raffa D; Bajardi ML; Caruso A; Cutuli V; Amico-Roxas M
    Farmaco; 1992 Apr; 47(4):465-75. PubMed ID: 1388594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological studies of o-chloro-alpha-[(tert.-butylamino)methyl]benzylalcohol hydrochloride (C-78), a new bronchodilator. III. Actions on the nervous systems and miscellaneous organs.
    Uesaka I; Kubo S; Matsubara I; Kasé Y
    Arzneimittelforschung; 1977 Jul; 27(7):1439-45. PubMed ID: 578469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclohexylphenoxy amidoximes and imidazolines with antidepressive and alpha-adrenergic activity.
    Picciòla G; Carissimi M; Ravenna F; Gentili P; Carenini G
    Arzneimittelforschung; 1979; 29(5):729-38. PubMed ID: 40574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The general pharmacology of a novel antitussive compound RU 20201.
    Pickering RW; James GW
    Arzneimittelforschung; 1979; 29(4):642-6. PubMed ID: 314807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties of thiazolinobutazone (LAS 11 871). III. General pharmacology, ulcerogenic effects and acute toxicity.
    Colombo M; Márquez M; Roberts DJ
    Arzneimittelforschung; 1976; 26(7):1347-56. PubMed ID: 1036923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacodynamic properties of fluproquazone.
    Hill RC; Foote RW; Roemer D
    Arzneimittelforschung; 1981; 31(5a):873-82. PubMed ID: 6973980
    [No Abstract]   [Full Text] [Related]  

  • 17. [General pharmacological effects of flupentixol].
    Ueki S; Watanabe S; Morimot Y; Masuda M
    Igaku Kenkyu; 1971 Jul; 41(5):441-51. PubMed ID: 5165981
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
    Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
    Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General pharmacological properties of muroctasin.
    Kojima H; Hirohashi M; Kasai Y; Takasuna K; Fukumoto C; Akashi A
    Arzneimittelforschung; 1988 Jul; 38(7A):1002-9. PubMed ID: 3190791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.